Jafron Biomedical Co (SZSE:300529) EBIT per Share : ¥0.85 (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Jafron Biomedical Co EBIT per Share?

Jafron Biomedical Co's EBIT per Share for the three months ended in Mar. 2024 was ¥0.44. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.85.

During the past 12 months, the average EBIT per Share Growth Rate of Jafron Biomedical Co was -23.40% per year. During the past 3 years, the average EBIT per Share Growth Rate was -18.30% per year. During the past 5 years, the average EBIT per Share Growth Rate was 8.30% per year. During the past 10 years, the average EBIT per Share Growth Rate was 21.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Jafron Biomedical Co's EBIT per Share or its related term are showing as below:

SZSE:300529' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -18.3 Med: 18.05 Max: 49.3
Current: -18.3

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Jafron Biomedical Co was 49.30% per year. The lowest was -18.30% per year. And the median was 18.05% per year.

SZSE:300529's 3-Year EBIT Growth Rate is ranked worse than
76.55% of 725 companies
in the Medical Devices & Instruments industry
Industry Median: 5.9 vs SZSE:300529: -18.30

Jafron Biomedical Co's EBIT for the three months ended in Mar. 2024 was ¥356 Mil.

Jafron Biomedical Co EBIT per Share Historical Data

The historical data trend for Jafron Biomedical Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jafron Biomedical Co EBIT per Share Chart

Jafron Biomedical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.85

1.25

1.76

1.34

0.75

Jafron Biomedical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															0.30	0.13	0.23	0.05	0.44

Jafron Biomedical Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Jafron Biomedical Co's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	575.353	/	765.776
=	0.75

Jafron Biomedical Co's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	356.287	/	814.782
=	0.44

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.85

Jafron Biomedical Co (SZSE:300529) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Jafron Biomedical Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Jafron Biomedical Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Jafron Biomedical Co (SZSE:300529) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jafron Biomedical Co Ltd (SZSE:300529) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 98, Science and Technology 6th Road, High-tech Zone, Guangdong Province, Zhuhai, CHN, 519085

Website

http://www.jafron.com

Jafron Biomedical Co Ltd is a China-based company engaged in the research, development, production, and sales of biomaterials and medical devices. It offers solutions for kidney disease, poisoning, rheumatic immune solution, critical illness and liver disease. The company's products include JFYC-100 pre-punching machine, DX-10 blood purifier, and HA resin hemoperfusion.

Executives

Li Feng	Director
He Xiao Lian	Executives
Dong Fan	Directors, Directors, and Executives
Ceng Kai	Directors, executives
Tang Xian Min	Directors, executives
Zhang Ming Yuan	Secretary Dong
Fang Li Hua	Supervisors
Zhang Guang Hai	Directors, executives
Li De Zhi	Executives
Lu Shao Zhang	Executives

Jafron Biomedical Co (SZSE:300529) Headlines

No Headlines